Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100

Journal of Clinical Investigation

Volumn 106, Issue 12, 2000, Pages 1501-1510

  Veniant M M ^a   Sullivan, M A ^a   Kim, S K ^a   Ambroziak, P ^a   Chu, A ^a   Wilson, M D ^a   Hellerstein, M K ^a   Rudel, L L ^a   Walzem, R L ^a   Young, S G ^a  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B100; LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA SYNTHESIS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0034526420     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10695     Document Type: Article

References (50)

1. Cholesterol and coronary heart disease. A new era
2. Atherogenicity of triglyceride-rich lipoproteins
3. Quantitative studies of transfer in vivo of low density, Sf 12-60, and Sf 60-400 lipoproteins between plasma and arterial intima in humans
4. Familial hypercholesterolemia
5. Type III hyperlipoproteinemia (dysbetalipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism
6. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men
7. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells
8. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
9. Low density lipoprotein receptor-negative mice expressing apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein(a)
10. A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet
11. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression
12. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
13. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
14. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery
15. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice
16. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100
17. The two-receptor model of lipoprotein clearance: Tests of the hypothesis in "knockout" mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins
18. Phenotypic analysis of mice expressing exclusively apolipoprotein B48 or apolipoprotein B100
19. Lipoprotein clearance mechanisms in LDL receptor-deficient "apo-B48-only" and "apo-B100-only" mice
20. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a)
21. Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes
22. Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human apoB100-overexpressing transgenic mice
23. Generation of monoclonal antibodies specific for mouse apolipoprotein B-100 in apolipoprotein B-48-only mice
24. Transgenic mice that overexpress mouse apolipoprotein B. Evidence that the DNA sequences controlling intestinal expression of the apolipoprotein B gene are distant from the structural gene
25. Overfeeding increases very low density lipoprotein diameter and causes the appearance of a unique lipoprotein particle in association with failed yolk deposition
26. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice
27. Protein measurement with the folin phenol reagent
28. Measurement of cell proliferation by labeling of DNA with stable isotope-labeled glucose: Studies in vitro, in animals, and in humans
29. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
30. Factors influencing T-cell turnover in HIV-1-seropositive patients
31. A new in vivo stable isotope method for measuring mammary epithelial cell proliferation
32. 2O incorporation into DNA
33. Familial apolipoprotein E deficiency
34. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. I. The inhibition of experimental cholesterol atherosclerosis in alloxan diabetes. II. The effect of alloxan diabetes on the retrogression of experimental cholesterol atherosclerosis
35. Reduced atherogenesis in cholesterol-fed diabetic rabbits. Giant lipoproteins do not enter the arterial wall
36. Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits
37. Transfer of plasma lipoprotein components and of plasma proteins into aortas of cholesterol-fed rabbits. Molecular size as a determinant of plasma lipoprotein influx
38. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits. Roles of plasma concentration, extent of aortic lesion, and lipoprotein particle size as determinants
39. Selective retention of VLDL, IDL, and LDL in the arterial intima of genetically hyperlipidemic rabbits in vivo. Molecular size as a determinant of fractional loss from the intima-inner media
40. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet
41. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men
42. The oxidation hypothesis of atherosclerosis
43. Older lipoproteins are more susceptible to oxidation: A linking mechanism for the lipid and oxidation theories of atherosclerotic cardiovascular disease
44. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages
45. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice
46. Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice
47. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation
48. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption
49. Massive xanthomatosis and altered composition of atherosclerotic lesions in hyperlipidemic mice lacking acyl CoA:cholesterol acyltransferase 1
50. Lipoprotein clearance mechanisms in LDL receptor-deficient "apoB-48 only" and "apoB-100-only" mice